BioHarvest Sciences Inc (NASDAQ:BHST, FRA:8MV0) management has been invited to attend the 38th annual Roth Conference taking place on March 22-24 in California.
CEO Ilan Sobel, who is scheduled to host one-on-one meetings with institutional investors throughout the event, said it is "a high-profile opportunity" to highlight the BioHarvest story, following a Q4 2025 financing round that means the company is "fully funded from a near-term capex perspective, and focused on driving accelerated growth in both our CDMO and consumer product businesses."